Tag: Clots
Tenecteplase Has Similar Safety to TPA for Acute Ischemic Stroke
TNK associated with higher likelihood of excellent functional outcome and reduced disability at three months
Risk for Venous Thromboembolism Up for Those With Sickle Cell Trait
Risk for pulmonary embolism was higher than that of isolated deep vein thrombosis in SCT
Oversight of DOAC Prescribing Beneficial for A-Fib, VTE Patients
Oversight identifies errors, especially in a-fib patients, who mainly have alerts for off-label prescribing during follow-up period
Bariatric Surgery Tied to Higher Short-Term Risk for Venous Thromboembolism
However, at one and five years after surgery, risk for venous thromboembolism and pulmonary embolism was lower
Rate of Venous Thromboembolism Increased With Cancer Surgery
Cause-specific hazard ratio for pulmonary embolism peaked after discharge, then plateaued 60 to 90 days later
Bivalent COVID-19 Shot Effective for Preventing Thromboembolic Events
Findings seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease
Clot Risk High With Oral Contraceptives for Those at Genetic Risk
Risk highest in the first two years, regardless of genetic risk, and lower for continued use
Mechanical Thrombectomy Safe, Effective for High-Risk Pulmonary Embolism
No deaths seen at 30-day follow-up in real-world cohort
Estrogen-Linked Thrombotic Biomarkers Drop After Cessation of Combo Pill
Decreases seen at week 12, with most of the decrease achieved at two and four weeks after cessation of combined hormonal contraceptives
Link Explored for NSAID Use, Hormonal Contraception, VTE Risk
NSAID use positively linked to VTE, with extra VTE events in those with concomitant high-, medium-risk contraception use
